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INTRODUCTION
Antibiotics have been crucial in the medical advancements 
towards decreasing mortality due to microbial infections; 
however, a group has emerged as multidrug resistant infections 
arising in healthcare settings, also called nosocomial pathogens7. 
Antibiotics work to eliminate bacterial infections by interrupting 
protein synthesis or DNA replication, which essentially renders 
the bacteria inactive3. However, pathogenic bacteria are able to 
adapt and resist antibiotics by random mutations or transference 
of resistant genetic material from other bacteria3. The ESKAPE 
pathogens, which is an acronym for the six bacterial strains 
Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter spp., are resistant to antimicrobial 
agents and contribute to increased mortality rates among 
nosocomial infections4,7. Identified by World Health Organization 
(WHO) as dangerous pathogens, ESKAPE bacterial strains pose a 
public health threat because their antibiotic resistance increases 
health care costs and decreases the ability to effectively treat these 
infections4-5,9. The health-care field acknowledges the dire need 
for developing new treatment strategies to reduce ESKAPE 
pathogens in prevalence and mortality risk with new research 
studies, like this one.
Further investigative research needs to focus on safe, bacterial 
related strains that are related to the ESKAPE strains and non-
pathogenic. Generally, bacteria are prokaryotic microbes with cell 
walls that can be beneficial or pathogenic to human beings. They 
replicate through binary fission on either cultured planktonic or 
agar plated surfaces3. This research study is conducted on 
Escherichia coli, a safe-relative of Klebsiella pneumoniae, and on 
Bacillus subtilis. E. coli are single or paired rods that are Gram-
negative and motile, usually found within the intestines of animal 
hosts8. B. subtilis, is rod-shaped, Gram-positive that forms spores 
under stressful conditions, which contributes to their motile 
abilities6. Various treatment strategies are underway to combat 
multi-drug resistant bacteria, such as antibiotics in combination, 
and applying silver nanoparticles or photodynamic light therapy4. 
A new research program, Tiny Earth Project Initiative (TEPI), has 
emerged to find antibiotic options to stop the ESKAPE pathogens 
while discovering vital research about lost soil sustainability
TEPI is an international research network of students and 
professors that work to accomplish three goals: student-originated 
research, identifying novel antibiotic-producing microbes in local 
soil samples, and understanding how to maintain microbial 
diversity while combating soil erosion3. The purpose of this 
research project is to identify potential antibiotic-producing 
bacteria from local soil samples to take the next steps in 
developing new antibiotics to combat ESKAPE-related strains, 
such as Escherichia coli, and Bacillus subtilis. 
METHODS
Unless described otherwise, the bacterial strains and protocols used 
in this study were provided by the Tiny Earth Project Initiative 
(TEPI) 3. 
▪ On January 9th, 2020, a soil sample was collected from Duck 
Creek Park, Bettendorf, IA. (Latitude 41.54; Longitude, -90.53).
▪ A 1.65 gram dry soil sample was transformed into a slurry mix. 
From the slurry, serial dilutions of the mix were plated onto three 
types of media: LB agar, 10% TSA, and PDA. The bacterial 
cultures were incubated at 28°C-30°C for 24-48 hours.
▪ Master plates were created by streaking bacterial colonies from 
the serial dilution plates onto their respective media. 
▪ Then, the same bacterial colonies were streaked onto petri dishes 
with spread bacterial strains of Bacillus subtilis and Escherichia 
coli to test for potential antibiotic producers.
▪ Once antibiotic producers were identified and confirmed,  colony 
PCR was completed and gel electrophoresis isolated DNA of the 
bacterial colonies. DNA was removed from the gel and purified 
for further 16S rRNA sequencing at University of Iowa, Iowa 
Institute of Human Genetics. 
▪ NCBI BLAST analyzed the data, identifying a genus.
DISCUSSION
NCBI BLAST analysis determined the bacterial strains were likely 
from the genus of Bacillus, which makes sense as an antibiotic 
producer pulled from the soil2. Both soil isolates, CP-8-LB-B. 
subtilis and CP-26-TSA-B. subtilis, demonstrated antibiotic abilities 
when halos or zones of inhibition were produced against B. subtilis. 
Bacillus lies within the phyla of Firmicutes and ranges 0-7% in 
being found in soil samples with a mean contribution of 2%1. 
Future direction will look into understanding the organic molecular 
structure of Bacillus using NMR spectrometry3. Also, researchers 
will analyze other soil samples in the area of the current soil sample 
to obtain further understanding of local soil bacteria. 
Fig. 1. The four 
streak plates isolated 
separate colonies on 
two types of 
respective media 
(LB & 10%TSA). 
They were streaked 
to isolate pure 
colonies.
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Fig. 3. The agarose gel electrophoresis isolated the DNA of confirmed 
antibiotic-producing soil isolates, CP-8-LB-B. subtilis and CP-26-TSA-B. 
subtilis, which were removed and purified for further 16S rRNA sequencing. 
Lane 5 contained CP-8-LB-B. subtilis and maintained a length of between 1 
and 1.5 Kb. Lane 7 contained CP-26-TSA-B. subtilis and maintained a 
length of about 1.5 to 2 Kb. Lanes 2, 4, and 6 were skipped to provide room 
for DNA purification. The DNA from lanes 5 and 7 were sent for 16S rRNA 
sequencing at University of Iowa, Iowa Institute of Human Genetics. 
The tables above show the NCBI BLAST program analysis for the 16S rRNA 
sequence after the primers 27F and 1492R for both soil isolates, CP-8-LB-B. 
subtilis and CP-26-TSA-B. subtilis, and determined them to be of the Bacillus 
genus2. Query coverage indicates the percent of the inputted sample compared 
against other known bacteria. Percent identity indicates the percentage of 
identical base pairs of the inputted sample against the matched database 
bacteria. The probability that the hits in the database are pulled out by random 
are found with any numerical value in the E value. Both soil isolates show 
high validity indicated by above 98% on QC and PI, and 0 in the E value. 
Fig. 2. Three soil isolates produced zones of inhibition (halos) when 
tested for antibiotic producing abilities against B. subtilis and E. coli: 
CP-1-LB-B.subtilis, CP-8-LB-B. subtilis, and CP-26-LB-B. subtilis. Soil 
isolate 8 on LB and 26 on TSA produced bigger halos than 1 on LB, 
which indicates further testing confirmation on soil isolate 1 is 
necessary. Both CP-8-LB-B. subtilis and CP-26-TSA-B. subtilis were 
effective against Bacillus subtilis, yet showed no halo effects or zones of 
inhibition against E. coli.







Bacillus mobilis strain MCCC 1A05942 99% 0 99.72%
Bacillus thuringiensis strain NBRC 101235 99% 0 99.65%
Bacillus toyonensis strain BCT-7112 99% 0 99.65%
Bacillus thuringiensis strain ATCC 10792 99% 0 99.65%
Bacillus thuringiensis strain IAM 120777 99% 0 99.65%







Bacillus mobilis strain MCCC 1A05942 98% 0 99.14%
Bacillus thuringiensis strain NBRC 101235 98% 0 98.93%
Bacillus toyonensis strain BCT-7112 98% 0 98.93%
Bacillus thuringiensis strain ATCC 10792 98% 0 98.93%
Bacillus thuringiensis strain IAM 120777 98% 0 98.93%
